- Home
- LDTC vs ESLA Comparison
LDTC vs ESLA Comparison
Compare LDTC & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LDTC
- ESLA
- Stock Information
- Founded
- LDTC 2007
- ESLA 2021
- Country
- LDTC Canada
- ESLA United States
- Employees
- LDTC N/A
- ESLA N/A
- Industry
- LDTC Blank Checks
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LDTC Finance
- ESLA Health Care
- Exchange
- LDTC Nasdaq
- ESLA Nasdaq
- Market Cap
- LDTC 37.5M
- ESLA 32.1M
- IPO Year
- LDTC N/A
- ESLA N/A
- Fundamental
- Price
- LDTC $0.53
- ESLA $1.03
- Analyst Decision
- LDTC Buy
- ESLA Strong Buy
- Analyst Count
- LDTC 2
- ESLA 1
- Target Price
- LDTC $3.00
- ESLA $16.00
- AVG Volume (30 Days)
- LDTC 133.2K
- ESLA 70.6K
- Earning Date
- LDTC 05-14-2025
- ESLA 05-20-2025
- Dividend Yield
- LDTC N/A
- ESLA N/A
- EPS Growth
- LDTC N/A
- ESLA N/A
- EPS
- LDTC N/A
- ESLA N/A
- Revenue
- LDTC $331,997.00
- ESLA N/A
- Revenue This Year
- LDTC $906.25
- ESLA N/A
- Revenue Next Year
- LDTC $149.88
- ESLA N/A
- P/E Ratio
- LDTC N/A
- ESLA N/A
- Revenue Growth
- LDTC 141.86
- ESLA N/A
- 52 Week Low
- LDTC $0.22
- ESLA $0.63
- 52 Week High
- LDTC $2.75
- ESLA $3.23
- Technical
- Relative Strength Index (RSI)
- LDTC 61.52
- ESLA 50.82
- Support Level
- LDTC $0.39
- ESLA $1.02
- Resistance Level
- LDTC $0.48
- ESLA $1.22
- Average True Range (ATR)
- LDTC 0.05
- ESLA 0.12
- MACD
- LDTC 0.02
- ESLA 0.01
- Stochastic Oscillator
- LDTC 62.57
- ESLA 47.62
About LDTC LeddarTech Holdings Inc.
LeddarTech Holdings Inc is a company that develops and provides comprehensive perception software solutions that enable the deployment of ADAS and autonomous driving (AD) applications. Its automotive-grade software applies AI and computer vision algorithms to generate accurate 3D models of the environment, allowing for decision-making and safer navigation. The company generates the majority of its revenue from France, Canada, and the United states.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.